{"ticker": {"uuid": "2eb16327-40f9-4a74-bdf2-ffe2d006ba71", "symbol": "300759", "name": "Pharmaron Beijing Co., Ltd.", "exchange": "SHZ", "country": "CN", "sector": "Healthcare", "industry": "Biotechnology"}, "articles": [{"title": "Pharmaron Forecasts Double-Digit Revenue Growth for Interim 2026 Results", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwgFBVV95cUxNZHBYWVpabnp4OEpGYVVKUkRkTWJrRmE0NFBYMjFjYkdMaVpqWlpjak5MS3R4N2pHMzYzN3RNZmhPMWV0ckt5Nk1TOEdIOGtDcTQwemstZy01dFptYTIxeDVYTW53QkdYS2twR3cyUGF5Wkt5cnRpUEh5aHB2OHMtTWJDNnZrdTdvQTFlbnN1ekIyd1I2NU1CMVh5MV85WkNkSjRYMnpxTHlFV29vaHlfV3NxZ1hfY1FGdFdhQ081YTF2QQ?oc=5", "source_name": "TipRanks", "published_at": "2026-07-13T13:16:39+00:00", "published_display": "13 Jul 2026 13:16", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Pharmaron Beijing (300759) Earnings: Preliminary 1H Net Income Increases by 4% to 10%", "summary": "", "url": "https://news.google.com/rss/articles/CBMi1AFBVV95cUxNdlI2T2x6NTlVWEdRZUNGX09UMFowX3RWREg1QVNIWXFBaVNTM3dWdlVhWHFMN01xUjIxS1Z4NkhzdXlhb01mUE9KYU45TzJfaUthUjh2bDlZdndkMDV4NlNnRGZkbklnc0Vnc1R4Rk9pZzZXMjNoUHRTejdNdHFLT2pYbTZJY1VKTmx1dkJxTWt0TTFvOGxucmthcExObHNlc25yTFk5SXFsNUFyZTBObzdGTk0yQ1lNOXg1bGRLUFdGTnBxWkhtcVZ6WHlLM2FhU2hmeA?oc=5", "source_name": "Smartkarma", "published_at": "2026-07-13T12:55:11+00:00", "published_display": "13 Jul 2026 12:55", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Pharmaron Acquires Biortus in China", "summary": "", "url": "https://news.google.com/rss/articles/CBMilwFBVV95cUxOdVZnSnpPSDBoOVVBeDN6QWstSWZzOHQ3VjlOTVdoSmg0WG12bXJXZ2h1Tk9pU2NYQ3lveURlRUxZaHUtajB1bjQtZ2ZMSWNVRlNvRXdFbW1TNWRIZ2ltWmJpeWZjc1VmWFRNNTlqaVpkWGxxc0c0LS1hU2haU0o4dHEybFRral9zdWZpTmk5YVlJcnMyT0Iw?oc=5", "source_name": "Business Wire", "published_at": "2025-10-28T07:00:00+00:00", "published_display": "28 Oct 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Pharmaron\u2019s Liverpool UK Gene Therapy CDMO Commences Major Site Expansion Following UK Government Grant to Support \u00a3151m Investment", "summary": "", "url": "https://news.google.com/rss/articles/CBMinAJBVV95cUxPZU1YWkRreHVnOFFsNVpLcjQtVlVGTjMybEZfVTZkcVRaOUhxNU5rc2dkcEw1RFpFdzBGLWlmdmVyZms5eko1Rkh2dVRoa0tVTHFZNkpkaUJvaUNNNHVmeFRDSWZDSTU4a1ppTUowaHB4TExNNHdkMzlwVjZ3aDI1OGEyQmQyNl9Ic2daYzM2VTdNdlNXRE1GeXVla3hyTVRPZ1ZKTS01cUZ6NW01dk9FVEIybDd5RXE3OUU5RzJfa216M2kyMExwbGdIZDhFVzFMcThRZmFrQ0xRZGw5Qng4UG9KR0FpNEF4Slk5MUNjMDFFb2xjeDBvS2sxZGNCMTZYMlpZQ2tpSjNXZERLeXZqeDNnT0lYbE85VkNsUg?oc=5", "source_name": "Business Wire", "published_at": "2023-03-29T07:00:00+00:00", "published_display": "29 Mar 2023 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Pharmaron Forecasts Double-Digit Revenue Growth for Interim 2026 Results", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwgFBVV95cUxNZHBYWVpabnp4OEpGYVVKUkRkTWJrRmE0NFBYMjFjYkdMaVpqWlpjak5MS3R4N2pHMzYzN3RNZmhPMWV0ckt5Nk1TOEdIOGtDcTQwemstZy01dFptYTIxeDVYTW53QkdYS2twR3cyUGF5Wkt5cnRpUEh5aHB2OHMtTWJDNnZrdTdvQTFlbnN1ekIyd1I2NU1CMVh5MV85WkNkSjRYMnpxTHlFV29vaHlfV3NxZ1hfY1FGdFdhQ081YTF2QQ?oc=5", "source_name": "TipRanks", "published_at": "2026-07-13T13:16:39+00:00", "published_display": "13 Jul 2026 13:16", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Pharmaron Beijing (300759) Earnings: Preliminary 1H Net Income Increases by 4% to 10%", "summary": "", "url": "https://news.google.com/rss/articles/CBMi1AFBVV95cUxNdlI2T2x6NTlVWEdRZUNGX09UMFowX3RWREg1QVNIWXFBaVNTM3dWdlVhWHFMN01xUjIxS1Z4NkhzdXlhb01mUE9KYU45TzJfaUthUjh2bDlZdndkMDV4NlNnRGZkbklnc0Vnc1R4Rk9pZzZXMjNoUHRTejdNdHFLT2pYbTZJY1VKTmx1dkJxTWt0TTFvOGxucmthcExObHNlc25yTFk5SXFsNUFyZTBObzdGTk0yQ1lNOXg1bGRLUFdGTnBxWkhtcVZ6WHlLM2FhU2hmeA?oc=5", "source_name": "Smartkarma", "published_at": "2026-07-13T12:55:11+00:00", "published_display": "13 Jul 2026 12:55", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Pharmaron Acquires Biortus in China", "summary": "", "url": "https://news.google.com/rss/articles/CBMilwFBVV95cUxOdVZnSnpPSDBoOVVBeDN6QWstSWZzOHQ3VjlOTVdoSmg0WG12bXJXZ2h1Tk9pU2NYQ3lveURlRUxZaHUtajB1bjQtZ2ZMSWNVRlNvRXdFbW1TNWRIZ2ltWmJpeWZjc1VmWFRNNTlqaVpkWGxxc0c0LS1hU2haU0o4dHEybFRral9zdWZpTmk5YVlJcnMyT0Iw?oc=5", "source_name": "Business Wire", "published_at": "2025-10-28T07:00:00+00:00", "published_display": "28 Oct 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Pharmaron\u2019s Liverpool UK Gene Therapy CDMO Commences Major Site Expansion Following UK Government Grant to Support \u00a3151m Investment", "summary": "", "url": "https://news.google.com/rss/articles/CBMinAJBVV95cUxPZU1YWkRreHVnOFFsNVpLcjQtVlVGTjMybEZfVTZkcVRaOUhxNU5rc2dkcEw1RFpFdzBGLWlmdmVyZms5eko1Rkh2dVRoa0tVTHFZNkpkaUJvaUNNNHVmeFRDSWZDSTU4a1ppTUowaHB4TExNNHdkMzlwVjZ3aDI1OGEyQmQyNl9Ic2daYzM2VTdNdlNXRE1GeXVla3hyTVRPZ1ZKTS01cUZ6NW01dk9FVEIybDd5RXE3OUU5RzJfa216M2kyMExwbGdIZDhFVzFMcThRZmFrQ0xRZGw5Qng4UG9KR0FpNEF4Slk5MUNjMDFFb2xjeDBvS2sxZGNCMTZYMlpZQ2tpSjNXZERLeXZqeDNnT0lYbE85VkNsUg?oc=5", "source_name": "Business Wire", "published_at": "2023-03-29T07:00:00+00:00", "published_display": "29 Mar 2023 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 64, "total_relevant": 4, "sentiment_summary": {"positive": 3, "negative": 0, "neutral": 1, "score": 62, "total": 4, "label": "Constructive news tone", "tone": "positive"}, "classifier": {"primary_event": "earnings", "primary_label": "Earnings", "confidence": 62, "events": [{"event": "earnings", "label": "Earnings", "weight": 1.1, "count": 2}, {"event": "general", "label": "Market update", "weight": 1.1, "count": 2}], "positive_events": 3, "negative_events": 0}, "market_context": {"has_market_context": true, "latest_close": 35.48, "latest_week": "2026-07-17", "one_week_move": 4.5, "four_week_move": 57.3, "twelve_week_move": 21.4, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": 1.008539, "market_dynamics_buy_signal": false, "relative_strength": 18.670427, "fair_value_gap": 34.4, "fair_value_label": "Materially above fair value", "fair_value_tone": "negative", "expectation_direction": "negative", "expectation_probability": 43.6713, "reaction_label": "Price confirming higher", "reaction_tone": "positive", "market_sentence": "+4.5% over one week, +57.3% over four weeks, trend inactive, and materially above fair value."}, "interpretation": {"label": "News confirmed by price", "tone": "positive", "classification": "confirmed_positive", "summary": "Constructive news tone is being confirmed by positive weekly price action.", "confidence": 66, "badges": ["Sentiment-trend disagreement", "Positive but stretched"], "opportunities": [], "risks": ["Positive news is arriving while the Sharemaestro trend signal is inactive.", "Constructive tone is arriving with price materially above fair value."], "event_label": "Earnings", "sentiment_word": "constructive"}, "charts": {"sources": [{"label": "Business Wire", "count": 2}, {"label": "TipRanks", "count": 1}, {"label": "Smartkarma", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 4}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Earnings", "count": 2}, {"label": "Market update", "count": 2}]}, "insights": [{"label": "Weighted tone", "value": "62/100", "tone": "positive", "text": "Constructive news tone"}, {"label": "Market reaction", "value": "News confirmed by price", "tone": "positive", "text": "Constructive news tone is being confirmed by positive weekly price action."}, {"label": "Primary event", "value": "Earnings", "tone": "positive", "text": "62/100 classification confidence."}, {"label": "Company focus", "value": "4", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "0", "tone": "neutral", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "+4.5% over one week, +57.3% over four weeks, trend inactive, and materially above fair value."}, {"label": "Latest direct headline", "value": "Positive", "tone": "positive", "text": "Pharmaron Forecasts Double-Digit Revenue Growth for Interim 2026 Results"}], "updated_at": "2026-07-22T02:32:57.501676+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}